Cellular imaging

#Alzheimer's #Cellular imaging #Drug discovery #Imaging #Japan #Nanobodies #Neuroscience

Nanobody-based 3D imaging boosts neuroscience research

Scientists have created a nanobody-based method that enables ultra-fast, high-resolution 3D mapping of neurons and glia in thick brain tissues.  The researchers from Japan have developed a fast, high-sensitivity three dimensional immunohistochemistry (3D-IHC) method using nanobodies fused with peroxidase and a novel signal amplification system.  … Read More

#News

Red blood cells
#Assays #Cellular imaging #Drug discovery #High throughput screening #In vitro #Technical Note

Technical Note: Unlocking high-throughput potential

A new Technical Note from Lonza is now available entitled ‘Primary Human Umbilical Vein Endothelial Cells: A Qualitative, Real-time, In-vitro Tube Formation Assay‘. Download the Technical Note to learn more about these unique features: Co-culture model with high biological relevance Compatible with live-cell imaging which allows for real-time… Read More

#News

#Artificial intelligence (AI) #Cellular imaging #Generative AI #Laboratory data #Machine learning

How AI and ML empower a new world of drug discovery

David Gosalvez, Head of Product Strategy and Zev Wisotsky, Senior Principle Marketing Manager for Biologics at Revvity Signals, highlight how three powerful AI and ML capabilities are driving lab innovation: enhancing data accessibility, enabling intelligent chemical reaction recommendations, and automating complex cellular imaging. Enhancing data accessibility with generative AI A… Read More

#Exclusive Content

Two scientists in a research laboratory
#App note #Artificial intelligence (AI) #Assays #Cell culture #Cellular assays #Cellular imaging

Discover how to streamline migration assays with in-incubator monitoring

Cell migration assays can be time-consuming and challenging, from identifying and ensuring assays are imaged at the appropriate time, to properly measuring wound closure. In this new App Note, discover the benefits of Evident’s CM cell culture monitors, which provide label-free, quantitative results, consistent results throughout your lab, and are… Read More

#News

#Artificial intelligence (AI) #Assays #Cell culture #Cellular assays #Cellular imaging

Streamline migration assays with in-incubator monitoring

Cell migration assays can be time-consuming and challenging, from identifying and ensuring assays are imaged at the appropriate time, to properly measuring wound closure. Evident’s CM cell culture monitors provide label-free, quantitative results, consistent results throughout your lab, and are cost-effective. Researchers at ACEL simplified the cell migration process by… Read More

#Resources

Biomarkers concept
#Antibodies #Biomarkers #Cell signalling #Cellular imaging #Microsystems

Data collection that empowers scientific discoveries 

Leica Microsystems and Cell Signaling Technology (CST) have announced a partnership to validate CST antibodies on the Cell DIVE multiplexed imaging solution, allowing researchers to design custom antibody biomarker panels.    Backed by a decade of research, the Cell DIVE iterative staining workflow enables the visualisation of over… Read More

#News

#Cellular imaging #Drug discovery #Medicines Discovery Catapult

MDC and ZEISS look to advance microscopy for early drug discovery  

A new partnership has been formed between Medicines Discovery Catapult (MDC) and technology group ZEISS to improve drug discovery using advanced microscopy solutions.  The partnership will combine MDC’s expertise in cell biology and drug discovery with ZEISS’ microscope instrumentation and image analysis capabilities. In particular, the organisations… Read More

#News

#Cellular imaging #Clinical trials #Data #Imaging

Medidata hits platform milestone  

Medidata’s Rave Imaging, the company’s cloud-based, secure clinical trial imaging management platform, has now supported more than 1,000 imaging studies.   Rave Imaging processes more than 100 million images annually. The technology provides real-time visibility into imaging-related trial activities to enhance study efficiency.   Paul McCracken, VP and… Read More

#News

#Cell painting #Cellular imaging #High Content Screening #Reagents

PerkinElmer launches first cell painting kit

PerkinElmer has launched the first cell painting kit as part of its new portfolio of PhenoVue cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside its microplates, automation, software and high-content screening instruments. With this entire screening workflow, researchers… Read More

#News